POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP SOLUTION

Land: Canada

Språk: engelsk

Kilde: Health Canada

Aktiv ingrediens:

SODIUM CHLORIDE; POTASSIUM CHLORIDE

Tilgjengelig fra:

BAXTER CORPORATION

ATC-kode:

B05BB01

INN (International Name):

ELECTROLYTES

Dosering :

450MG; 150MG

Legemiddelform:

SOLUTION

Sammensetning:

SODIUM CHLORIDE 450MG; POTASSIUM CHLORIDE 150MG

Administreringsrute:

INTRAVENOUS

Enheter i pakken:

1000ML

Resept typen:

Ethical

Terapeutisk område:

REPLACEMENT PREPARATIONS

Produkt oppsummering:

Active ingredient group (AIG) number: 0213340004; AHFS:

Autorisasjon status:

MARKETED

Autorisasjon dato:

2008-03-31

Preparatomtale

Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 1 of 14_
PRESCRIBING INFORMATION
POTASSIUM CHLORIDE IN 0.45% SODIUM CHLORIDE INJECTION, USP
IN PLASTIC CONTAINER
VIAFLEX
Container
20 mmol/L Potassium Chloride in 0.45% Sodium Chloride Injection
SOLUTION FOR INFUSION
Solutions Affecting the Electrolyte Balance
BAXTER CORPORATION
Mississauga, ON L5N 0C2
Date of Revision:
December 10, 2018
Control No. 221539
Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 2 of 14_
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
....................................................................................3
INDICATIONS AND CLINICAL USE
..........................................................................................3
CONTRAINDICATIONS
...............................................................................................................3
WARNINGS AND PRECAUTIONS
..............................................................................................3
SPECIAL POPULATIONS
.............................................................................................................7
ADVERSE REACTIONS
................................................................................................................8
DRUG INTERACTIONS
................................................................................................................8
DOSAGE AND ADMINISTRATION
............................................................................................9
INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL
............................................10
DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
..................................11
OVERDOSE
..................................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
........................................................................13
STORAGE AND STABILITY
..................